Yes, deep vein thrombosis (DVT) is formally classified as a cardiovascular disease. The World Health Organization includes DVT and pulmonary embolism in its official list of cardiovascular diseases (CVDs), defined as disorders of the heart and blood vessels. The American Heart Association also treats venous blood clots as part of cardiovascular health, publishing clinical guidelines on their management. Still, DVT behaves quite differently from the conditions most people picture when they hear “cardiovascular disease,” like heart attacks and strokes, and those differences matter.
Why DVT Counts as Cardiovascular Disease
Cardiovascular disease is an umbrella term covering any disorder of the heart and blood vessels. Most people associate it with arterial problems: clogged coronary arteries, strokes, and peripheral artery disease. DVT affects veins rather than arteries, but veins are still blood vessels, and a clot that forms in a deep leg vein can travel to the lungs and directly compromise heart function. That connection to the cardiovascular system is why the WHO lists DVT alongside coronary heart disease, cerebrovascular disease, and congenital heart defects as a recognized CVD.
In the United States, up to 900,000 people are affected by venous thromboembolism (VTE) each year, and an estimated 60,000 to 100,000 die from it annually. Those numbers put DVT and its complications in the same conversation as other major cardiovascular killers.
How DVT Differs From Arterial Heart Disease
Even though DVT sits under the cardiovascular umbrella, the biology behind it is distinct. Arterial clots, the kind that cause heart attacks and most strokes, are driven primarily by platelet activation. Platelets clump together at sites of damaged artery walls, often where cholesterol plaques have built up. Venous clots form through a different mechanism: activation of the body’s clotting cascade, producing clots that are rich in a mesh-like protein called fibrin rather than dominated by platelets.
This distinction shapes treatment. Arterial conditions are often managed with antiplatelet drugs (like aspirin), while DVT is treated with anticoagulants, medications that slow the clotting cascade. Antiplatelet drugs do offer some protection against venous clots, but anticoagulants are far more effective for DVT. In practice, though, the line between these two systems is blurrier than textbooks once suggested. Anticoagulants also help prevent arterial clots in conditions like atrial fibrillation, and researchers increasingly view venous and arterial clotting as overlapping processes rather than completely separate ones.
Shared Risk Factors With Heart Disease
One of the strongest arguments for viewing DVT as part of cardiovascular disease is that many of the same risk factors drive both conditions. A large meta-analysis published in Circulation found that compared to people without these risk factors, the risk of venous thromboembolism was 2.33 times higher with obesity, 1.51 times higher with high blood pressure, and 1.42 times higher with diabetes. People with VTE also had significantly lower levels of HDL (“good”) cholesterol and higher triglycerides.
Smoking showed a more modest association (1.18 times higher risk), and high LDL cholesterol did not appear to be a significant factor. So the overlap is real but not complete. DVT also has its own unique triggers that arterial disease does not share: prolonged immobility, surgery, pregnancy, certain cancers, and inherited clotting disorders. If you’ve been told you have DVT, it doesn’t necessarily mean your arteries are in trouble, but the shared risk profile means paying attention to metabolic health benefits both sides of the circulatory system.
Does DVT Raise Your Heart Attack Risk?
Given those shared risk factors, a natural question is whether having DVT makes a future heart attack more likely. A population-based study tracked over 1,100 people with VTE and nearly 1,500 controls over several years. About 4.9% of the VTE group and 5.2% of the control group experienced a heart attack during follow-up, a difference that was not statistically significant. After adjusting for age, sex, diabetes, and other atherosclerosis risk factors, VTE was not a predictor of heart attack. Even among people whose DVT had no identifiable trigger (sometimes called unprovoked or idiopathic DVT), the risk of a future heart attack was no higher than in the general population.
The takeaway: while DVT and heart disease share some of the same underlying conditions like obesity and diabetes, having a DVT does not appear to independently set you up for a heart attack. They are related but not sequential.
When DVT Becomes a Direct Cardiac Emergency
DVT’s most dangerous cardiovascular impact comes not through gradual artery damage but through pulmonary embolism (PE). Most pulmonary embolisms originate from clots in the deep veins of the legs. A piece of clot breaks free, travels through the bloodstream, and lodges in the arteries of the lungs.
When a large clot blocks a significant portion of the lung’s blood vessels, the right side of the heart suddenly has to pump against much higher resistance. This pressure overload can stretch the right ventricle, impair its ability to contract, and reduce overall blood flow from the heart. The right ventricle, unlike the thicker left ventricle, is not built for high-pressure work. It can reach a tipping point where further dilation no longer generates enough force, leading to right-sided heart failure. Reduced blood flow to the heart muscle itself then creates a cycle of worsening oxygen deprivation, weakening contractions, falling blood pressure, and potentially fatal cardiac collapse.
This is why PE is classified by severity based on how much it affects the heart. Imaging of the right ventricle and blood markers of heart strain help determine whether someone with PE needs standard blood thinners or more aggressive clot-dissolving therapy.
How DVT Is Diagnosed
If DVT is suspected, the standard first steps are a clinical risk assessment and a blood test called D-dimer, which measures a substance released when clots break down. A negative D-dimer result is good at ruling DVT out, meaning it’s unlikely you have a clot. A positive result, however, doesn’t confirm DVT on its own because D-dimer can be elevated for many reasons, including recent surgery, infection, or pregnancy.
The standard imaging test is duplex ultrasound, which uses sound waves to visualize blood flow in the veins and detect blockages. It’s noninvasive, widely available, and has largely replaced older techniques like contrast venography, which required injecting dye into the foot. MRI and CT scans can also show clots but are not typically the first choice for diagnosing DVT in the legs.
Who Treats DVT
DVT typically falls under the care of vascular medicine specialists rather than cardiologists. A vascular doctor focuses on blood vessels throughout the body, while a cardiologist focuses on the heart itself. In practice, there is overlap: if a DVT leads to pulmonary embolism with cardiac complications, a cardiologist or a pulmonologist may become involved. Hematologists (blood specialists) also manage DVT, particularly when an underlying clotting disorder is suspected. Your primary care doctor can often coordinate initial treatment with blood thinners, referring to a specialist if the clot is extensive, recurrent, or complicated by PE.